Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Will Propose Drug GMP Quality Management Systems By December

This article was originally published in The Tan Sheet

Executive Summary

FDA expects to release a draft on improving the agency's drug GMP management systems by Dec. 1
Advertisement

Related Content

PAT Data Will Not Be Evaluated During Drug Inspections – FDA
PAT Data Will Not Be Evaluated During Drug Inspections – FDA
PAT Data Will Not Be Evaluated During Drug Inspections – FDA
PAT Selective Implementation Advised As Cost Control Measure
CDER Deputy Galson Will Run Drug Center For At Least Six Months
CDER Deputy Galson Will Run Drug Center For At Least Six Months
PAT Selective Implementation Advised As Cost Control Measure
FDA Drug GMP Dispute Resolution Guidance Allows 10 Days For Objections
FDA Drug GMP Dispute Resolution Guidance Allows 10 Days For Objections
Electronic Records Enforcement Relaxed During Part 11 Review, FDA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS095897

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel